Page 68 - GPD-3-4
P. 68

Gene & Protein in Disease                                               Drugs and immune infiltration in IPF



            mouse study demonstrated increased interaction between   research has been conducted on the role of TMEM100, a
            PDIA3 and SPP1, which is linked to reduced lung function   transmembrane protein with diverse biological functions,
            in patients with IPF.  Elevated blood MMP7 levels have   in IPF, warranting further investigation.  CPB2, also
                                                                                                  22
                             18
            been reported in subclinical familial pulmonary fibrosis,   known as plasma carboxypeptidase B, suppressed C5a-
            with  the  expression  of  MMP7  showing  a  correlation   induced inflammation in autoimmune arthritis models. 23,24
            with IPF severity.   MMP7 knockout mice  showed    However, research on CPB2 in IPF is sparse, and
                            19
            reduced bleomycin (BLM)-induced fibrosis, suggesting a   considering the involvement of the autoimmune system
            profibrotic role of MMP7 in IPF.  IL13RA2 is a hallmark   and inflammation in IPF pathogenesis, the role of CPB2
                                      20
            of IPF but cannot predict acute exacerbation.  Limited   in IPF warrants further exploration. VIPR1, a G-protein-
                                                  21
                                                               coupled receptor predominantly expressed in healthy
                                                               tissues, is involved in various physiological processes,
                                                               including glycogen metabolism and immune system
                                                               modulation.  VIPR1 is associated with several cancers,
                                                                         25
                                                               with high expression levels in breast, gastric, and colorectal
                                                               cancers and low expression levels in lung and liver cancers.
                                                               It is associated with cancer migration, invasion, cell
                                                               proliferation,  and  differentiation. 26,27   However,  research
                                                               on VIPR1 in IPF is limited, making its function worth
                                                               exploring.
                                                                 Further analysis revealed  COL15A1 and  COL6A3 as
                                                               hub genes. COL15A1 encodes the alpha chain of collagen
                                                               XV, primarily produced by mesenchymal cells such as
                                                               myocytes and adipocytes. It possesses antiangiogenic and
                                                               antitumor properties and plays a key role in maintaining
                                                               tissue homeostasis in various organs, such as the liver, eye,
            Figure  7. Prediction of potential drugs targeting hub genes using   kidney, and central nervous system. 28,29  Although research
            DrugBank, CTD, and DGIdb. Green squares represent drugs/compounds,   suggests a link between COL15A1 and IPF development,
                                                                                                            30
            and red circles represent genes
            Abbreviations: CTD: Comparative Toxicogenomics Database; DGIdb:   the mechanisms underlying this link remain poorly
            Drug-Gene Interaction Database.                    understood. In contrast,  COL6A3 encodes a component
                         A                                     B











                         C                                     D













            Figure 8. Macromolecular docking images of potential drugs with COL15A1 and COL6A3. (A) Molecular docking of cyclosporine and COL15A1.
            (B) Molecular docking of cyclosporine and COL6A3. (C) Molecular docking of dexamethasone and COL6A3. (D) Molecular docking of (+)-JQ1
            compound and COL6A3.
            Abbreviations: COL15A1: Collagen type XV alpha 1 chain; COL6A3: Collagen type VI alpha 3 chain.


            Volume 3 Issue 4 (2024)                         10                              doi: 10.36922/gpd.4101
   63   64   65   66   67   68   69   70   71   72   73